# Understanding Outcomes With the EMBLEM™ S-ICD in Primary Prevention Patients With Low Ejection Fraction

Study · id `cardio:ct-nct02433379` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02433379](<https://clinicaltrials.gov/study/NCT02433379>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02433379

Browse, organ or system: Heart  
Browse, condition area: Heart rhythm problems  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 1173 participants.

## Technical summary

Registry record NCT02433379. Allocation not applicable; no masking; primary purpose supportive care. Start 2015-06-09 (actual); primary completion 2019-12-06 (actual). Results posted on 2021-01-08.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose supportive care
- Phase: Not applicable
- Enrolled: 1173 participants (enrolled count; ClinicalTrials.gov record NCT02433379, source copy `cardio:ctgov-nct02433379-2025-03-24`, retrieved 2026-10-26)
- Started: 2015-06-09 (actual) (ClinicalTrials.gov record NCT02433379, source copy `cardio:ctgov-nct02433379-2025-03-24`, retrieved 2026-10-26)
- Primary completion: 2019-12-06 (actual) (ClinicalTrials.gov record NCT02433379, source copy `cardio:ctgov-nct02433379-2025-03-24`, retrieved 2026-10-26)
- Completion: 2019-12-06 (actual) (ClinicalTrials.gov record NCT02433379, source copy `cardio:ctgov-nct02433379-2025-03-24`, retrieved 2026-10-26)
- Results first posted: 2021-01-08 (ClinicalTrials.gov record NCT02433379, source copy `cardio:ctgov-nct02433379-2025-03-24`, retrieved 2026-10-26)
- Countries: United States; Belgium; Canada; Denmark; France; Germany; Italy; Netherlands; Poland; Puerto Rico; Spain; Switzerland; United Kingdom (ClinicalTrials.gov record NCT02433379, source copy `cardio:ctgov-nct02433379-2025-03-24`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02433379-2025-03-24`, retrieved 2026-10-26)

## The registry's words

- Brief title: Understanding Outcomes With the EMBLEM™ S-ICD in Primary Prevention Patients With Low Ejection Fraction
- Acronym: UNTOUCHED
- Condition: Ventricular Fibrillation
- Condition: Ventricular Tachycardia
- Condition: Low Cardiac Output
- Intervention (Device): EMBLEM S-ICD System
- Lead sponsor: Boston Scientific Corporation
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Ventricular tachycardia (`cardio:ventricular-tachycardia`)
- Registry lists this organization as the lead sponsor: Boston Scientific (`cardio:boston-scientific`)

## Provenance

Content hash: 506f220843fe980a8340f1e7f6bcf9944ce8a0d13d136a7112e532369024a766
Last substantive edit: 2026-10-31
Evidence last checked: Not recorded
